How It Works (The Science): P-21 is able to cross the blood-brain barrier, where it stimulates the proliferation and differentiation of neural stem cells
Because TB-500 distributes systemically regardless of injection site, there is no clinical requirement to inject near the injury
Specific mutations in PARK genes such as: DJ1, SNCA, PRKN, and PINK1 typically manifest as early-onset PD
Thymosin Beta-4 and its derivatives, including TB-500, are listed under section S2.3 (Growth Factors and Growth Factor Modulators) as a non-Specified Substance, prohibited at all times in and out of competition
Batch CoA: per-lot certificate listing HPLC purity, mass-spec result, peptide content (commonly 70 to 90 percent by amino acid analysis), water content (Karl Fischer, below 8 percent), and acetate counter-ion content